[PDF][PDF] Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment

S Bahadoram, M Davoodi, S Hassanzadeh… - G Ital Nefrol, 2022 - researchgate.net
Renal cell carcinoma (RCC) is the most common type of urogenital cancer. It has a mortality
rate of 30-40% and is more commonly seen in men than women. In addition to gender, other …

β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - ASPET
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

Epidemiology of renal cell carcinoma: 2022 update

L Bukavina, K Bensalah, F Bray, M Carlo… - European urology, 2022 - Elsevier
Context International variations in the rates of kidney cancer (KC) are considerable. An
understanding of the risk factors for KC development is necessary to generate opportunities …

Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis

J Cen, Y Liang, Y Huang, Y Pan, G Shu, Z Zheng… - Molecular cancer, 2021 - Springer
Background There is increasing evidence that circular RNAs (circRNAs) have significant
regulatory roles in cancer development and progression; however, the expression patterns …

The tumor immune microenvironment in clear cell renal cell carcinoma

CU Monjaras-Avila, AC Lorenzo-Leal… - International journal of …, 2023 - mdpi.com
Clear cell renal cell carcinoma (ccRCC) is a type of kidney cancer that arises from the cells
lining the tubes of the kidney. The tumor immune microenvironment (TIME) of ccRCC is a …

Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study

Z Du, W Chen, Q Xia, O Shi, Q Chen - Biomarker research, 2020 - Springer
Background Identifying the temporal trends of kidney cancer (KC) incidence in both the past
and the future at the global and national levels is critical for KC prevention. Methods We …

circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis

CP Gui, B Liao, CG Luo, YH Chen, L Tan, YM Tang… - Molecular Cancer, 2021 - Springer
Abstract Background Circular RNAs (circRNAs) have been indicated as potentially critical
mediators in various types of tumor progression, generally acting as microRNA (miRNA) …

Association of hypertension and blood pressure with kidney cancer risk: a nationwide population-based cohort study

CS Kim, KD Han, HS Choi, EH Bae, SK Ma… - Hypertension, 2020 - Am Heart Assoc
Data regarding health behavior-related factors and systolic or diastolic blood pressure to
evaluate the association between blood pressure and kidney cancer are lacking. Using …

Chrysin a promising anticancer agent: Recent perspectives

M Shahbaz, H Naeem, M Imran… - … Journal of Food …, 2023 - Taylor & Francis
Honey, propolis, and passionflower contain a flavone known as chrysin. Researchers are
studying chrysin to prove its potential to stop cancer cells growth. Chrysin cancer therapeutic …

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

FA Büttner, S Winter, V Stühler, S Rausch… - Genome Medicine, 2022 - Springer
Background Renal cell carcinoma (RCC) is a heterogeneous disease comprising
histologically defined subtypes. For therapy selection, precise subtype identification and …